Raisio forms strategic alliance with Italian health company Dr. Schar

In a recent turn of events, Finland based food group Raisio has joined forces with Italian health & well-being firm Dr. Schär by entering into a strategic alliance for manufacturing and product development. Helsinki-listed food group Raisio cited in a statement that the long-standing framework agreement would open up novel …

Optalysys unveils first optical co-processor system in the world

The FT:X2000 has resolution of 2048×1536 and can operate at up to 2400 frames per second. Optalysys Ltd., a company renowned for its light-speed optical AI systems recently announced that FT:X 2000, the first optical co-processor system in the world, will now be available to order. Experts are of the …

FDA approves Spravato nasal spray for treatment-resistant depression

Patients with severe depressive disorder are only considered for treatment with Spravato after they have undergone at least two antidepressant treatments. The Food and Drug Administration of the United States recently approved the Spravato nasal spray for the treatment of depression in adults in addition to oral antidepressants. It is …

Bayer files prostate cancer drug darolutamide with Japanese regulators

Bayer files prostate cancer drug darolutamide with Japanese regulators Bayer hopes to sway drug prescribers and for darolutamide to surpass the billion-euro annual sales milestone on approval. Bayer, the German multinational pharmaceutical company recently announced that it has filed darolutamide, its prostate cancer drug, with the Japanese regulators. It is …

Novo Nordisk confirms positive results for Ozempic in Type 2 diabetes

Novo Nordisk, the Demark-based diabetes care giant, has recently published positive results for a 30 week trial to evaluate the safety and efficacy of Ozempic (semaglutide) 1.0mg in combination with SGLT-2 inhibitor (SGLT-2i) treatment. The SUSTAIN 9 Phase IIIb study was reportedly performed in adults having Type 2 diabetes, who …

Japan’s AGC acquires Malgrat Pharma Chemicals to expand into Europe

Malgrat’s production lines are designed to handle the diverse scales needed, from pharmaceutical development phase to commercialization stage Japanese manufacturing firm AGC Inc., has recently announced that the company has completed the acquisition of Malgrat Pharma Chemicals (MPC), S.L.U, a Spain based synthetic pharmaceutical active ingredient producer. Apparently, the financial …

Abpro and China’s NJCTTQ join forces to develop bispecific antibodies

The firms will be using Abpro’s innovative DiversImmune technology for developing bispecific antibodies for immuno-oncology Abpro is reportedly teaming up with China-based NJCTTQ for developing new, innovative bispecific antibodies by deploying its antibody discovery platform. As part of the agreement, Abpro would receive up to $4 billion, which will be …

RMC, Quest Diagnostics team up to provide enhanced laboratory services

Leading diagnostics information services provider, Quest Diagnostics, and South Carolina’s Regional Medical Center (RMC) have announced a partnership aimed at enhancing the value and quality of diagnostic services for doctors and their patients. Under the new partnership agreement, Quest would be providing full laboratory management services. Steve Rusckowski, President, Chairman …

DuPont Nutrition & Health signs agreement with Lonza to develop HMOs

DuPont Nutrition & Health, through its agreement with Lonza, will be able to obtain a significant volume for the growing global HMOs market. Lonza Specialty Ingredients, biotechnology and specialty ingredient company and DuPont Nutrition & Health, the Specialty Products Division business of DowDuPont recently announced that they have entered into …